| Scrip code | 544583 |
|---|---|
| NSE Symbol | CANHLIFE |
| MSEI Symbol | NOTLISTED |
| ISIN | INE01TY01017 |
| Name of Company | Canara HSBC Life Insurance Company Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Type Of Insurance | Non-Linked Policy And Linked Policy |
| Date of start of financial year | 01-04-2026 |
| Date of end of financial year | 31-03-2027 |
| Date of board meeting when results were approved | 09-10-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 06-10-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Second quarter |
| Nature of report standalone or consolidated | Standalone |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Start date and time of board meeting | 09-10-2026 15:00:00 |
| End date and time of board meeting | 09-10-2026 16:00:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Direct |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Whether the company has any related party? | Yes |
| Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? | Yes |
| (I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public | NA |
| (II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. | NA |
| (III) Whether the company is a high value debt listed entity according to regulation 15 (1A)? | No |
| (a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication? | |
| (b) If answer to above question is No, please explain the reason for not complying. | |
| Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? | Yes |
| Latest Date on which RPT policy is updated | 09-02-2026 |
| Indicate Company website link for updated RPT policy of the Company | https://www.canarahsbclife.com/investor-relations/policies-and-code-of-conduct |
| Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? | No |
| No. of times funds raised during the quarter | |
| Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? | No |
| The Company has issued unsecured, rated, listed, subordinated, redeemable, fully-paid, non-cumulative, non-convertible debentures (NCDs) in the nature of ‘Subordinated Debt’ in accordance with the IRDAI (Registration, Capital Structure, Transfer of Shares and Amalgamation of Insurers) Regulations, 2024 aggregating to Rs 25,000 lakhs at a coupon rate of 8.15% per annum. The said NCDs were allotted on March 13, 2026, and are redeemable at the end of 10 years from the date of allotment with a call option with the Company to redeem the NCD post the completion of 5 years from the date of allotment and every year thereafter. | |
| Partiuclars | Current Quarter | Year to Date Figures | |
|---|---|---|---|
| Date of start of reporting period | 01-07-2026 | 01-04-2026 | |
| Date of end of reporting period | 30-09-2026 | 30-09-2026 | |
| Whether results are audited or unaudited | Unaudited | Unaudited | |
| Nature of report standalone or consolidated | Standalone | Standalone | |
| Policyholders' Accounts | |||
| 1 | Income | ||
| (i) | Gross premium income | ||
| (a) | First Year Premium | 64,190.00 | 1,10,796.00 |
| (b) | Renewal Premium | 1,64,091.00 | 2,75,829.00 |
| (c) | Single Premium | 29,844.00 | 87,606.00 |
| Gross premium income | 2,58,125.00 | 4,74,231.00 | |
| (ii) | Net premium income | 2,55,316.00 | 4,60,068.00 |
| (iii) | Income from investments (Net) | (3,342.00) | 2,23,537.00 |
| (iv) | Other income | ||
| 1 | Other Income | 640.00 | 1,299.00 |
| Total other income | 640.00 | 1,299.00 | |
| (v) | Transfer Of Funds From Shareholders Account | (1,514.00) | 894.00 |
| (vi) | Total Income | 2,51,100.00 | 6,85,798.00 |
| 2 | Expenses | ||
| (i) | Commission on | ||
| (a) | First Year Premium | 9,962.00 | 17,487.00 |
| (b) | Renewal Premium | 3,995.00 | 6,405.00 |
| (c) | Single Premium | 2,549.00 | 4,332.00 |
| Total Commission | 16,506.00 | 28,224.00 | |
| (ii) | Net Commission | 16,506.00 | 28,224.00 |
| (iii) | Operating Expenses related to insurance business | ||
| (a) | Employees remuneration and welfare expenses | 22,823.00 | 44,322.00 |
| (b) | Administration expenses | 0.00 | 0.00 |
| (c) | Advertisement and publicity | 0.00 | 0.00 |
| (b) | Other operating expenses | ||
| 1 | Other operating expenses | 13,273.00 | 24,777.00 |
| Total other operating expenses | 13,273.00 | 24,777.00 | |
| Total operating expenses related to insurance business | 36,096.00 | 69,099.00 | |
| Total Expenses of Management | 52,602.00 | 97,323.00 | |
| (iv) | Provisions for doubtful debts (including bad debts written off) | 0.00 | 0.00 |
| (v) | Provisions for diminution in value of investments | (120.00) | (120.00) |
| (vi) | Goods & Service tax charge on linked charges | 0.00 | 0.00 |
| (vii) | Provision for taxes | ||
| Current Tax | 0.00 | 0.00 | |
| Deffered Tax | 0.00 | 0.00 | |
| Total provision of taxes | 0.00 | 0.00 | |
| (viii) | Benefits Paid (Net) | 1,19,943.00 | 2,03,409.00 |
| (ix) | Change in actuarial liability | 79,824.00 | 3,79,555.00 |
| Total Expenses | 2,52,249.00 | 6,80,167.00 | |
| 3 | Net Surplus(Deficit) | (1,149.00) | 5,631.00 |
| 4 | Appropriations | ||
|---|---|---|---|
| (a) | Transferred to Shareholders A/c | 391.00 | 3,125.00 |
| (b) | Funds for Future Appropriation | (1,540.00) | 2,506.00 |
| 5 | Details of Surplus / Deficit | ||
| (a) | Interim bonus paid | 617.00 | 1,130.00 |
| (b) | Allocation of bonus to policyholders | 0.00 | 0.00 |
| (c) | Surplus shown in the Revenue Account | (1,149.00) | 5,631.00 |
| (d) | Terminal bonus paid | 0.00 | 0.00 |
| Total Surplus (Deficit ) | (532.00) | 6,761.00 | |
| 1 | Income | ||
|---|---|---|---|
| (i) | Transfer from Poliycholders' Account | 391.00 | 3,125.00 |
| (ii) | Income under Shareholders' Account | ||
| (a) | Investment Income | 3,514.00 | 6,969.00 |
| (b) | Other income | ||
| 1 | Other income | (125.00) | 8.00 |
| Total Other income | (125.00) | 8.00 | |
| Total income under shareholders account | 3,389.00 | 6,977.00 | |
| Total Income | 3,780.00 | 10,102.00 | |
| 2 | Expenses | ||
| (i) | Expenses other than those related to insurance business | 759.00 | 1,476.00 |
| (ii) | Transfer of funds to policyholders account | (1,514.00) | 894.00 |
| (iii) | Provisions for doubtful debts (including write off) | (286.00) | (240.00) |
| (iv) | Provisions for diminution in value of investments | 0.00 | 0.00 |
| Total Expenses | (1,041.00) | 2,130.00 | |
| 3 | Profit/ (loss) before tax | 4,821.00 | 7,972.00 |
| 4 | Provisions for tax | 516.00 | 853.00 |
| (i) | Current tax | 516.00 | 853.00 |
| (ii) | Deffered tax | 0.00 | 0.00 |
| 5 | Profit / (loss) after tax and before Extraordinary Items | 4,305.00 | 7,119.00 |
| 6 | Extraordinary Items (Net of tax expenses) | 0.00 | 0.00 |
| 7 | Profit/ (loss) after tax and Extraordinary Items | 4,305.00 | 7,119.00 |
| 8 | Dividend per share | ||
| (a) | Interim Dividend | 0.00 | 0.00 |
| (b) | Final Dividend | 0.00 | 0.00 |
| 9 | Profit/(Loss) carried to Balance Sheet | 56,366.00 | 56,366.00 |
| 10 | Paid up equity share capital | 95,000.00 | |
| 11 | Reserve & Surplus (excluding Revaluation Reserve) | 68,866.00 | 68,866.00 |
| 12 | Fair Value Change Account and Revaluation Reserve (Shareholders) | 0.00 | |
| 13 | Assets | ||
| (i) | Investments: | ||
| (a) | Shareholders | 1,93,285.00 | |
| (b) | Policyholders Fund excluding Linked Assets | 29,06,105.00 | |
| (c) | Assets held to cover Linked Liabilities | 19,20,608.00 | |
| Total Investments | 50,19,998.00 | ||
| (b) | Other Assets (Net of current liabilities and provisions) | 48,055.00 | |
| Total Assets | 50,68,053.00 | ||
| 14 | Analytical Ratios | ||
| (i) | Solvency Ratio | 180.4100 | 180.4100 |
| (ii) | Expenses of Management Ratio | 20.3800 | 20.5200 |
| (iii) | Policyholder 's liabilities to shareholders' fund | 2,977.54 | 2,977.54 |
| (iv) | Earnings per share (Rs.): | ||
| (a) | Basic and diluted EPS before extraordinary items (net of tax expense) for the period (not to be annualized) | 0.45 | 0.75 |
| (b) | Basic and diluted EPS after extraordinary items (net of tax expense) for the period (not to be annualized) | 0.45 | 0.75 |
| (v) | NPA ratios: (for policyholders' fund) | ||
| (a) | Gross NPAs | ||
| Non Linked | |||
| Par | 0.00 | 0.00 | |
| Non Par | 0.00 | 0.00 | |
| Linked | |||
| Par | 0.00 | 0.00 | |
| Non Par | 3,117.00 | 3,117.00 | |
| Net NPAs | |||
| Non Linked | |||
| Par | 0.00 | 0.00 | |
| Non Par | 0.00 | 0.00 | |
| Linked | |||
| Par | 0.00 | 0.00 | |
| Non Par | 0.00 | 0.00 | |
| % of Gross NPAs | |||
| Non Linked | |||
| Par | 0 | 0 | |
| Non Par | 0 | 0 | |
| Linked | |||
| Par | 0 | 0 | |
| Non Par | 0.0600 | 0.0600 | |
| % of Net NPAs | |||
| Non Linked | |||
| Par | 0 | 0 | |
| Non Par | 0 | 0 | |
| Linked | |||
| Par | 0 | 0 | |
| Non Par | 0 | 0 | |
| (vi) | Yield on Investments (on policyholders' fund) | ||
| (a) | Without unrealised gains | ||
| Non Linked | |||
| Par | 1.7900 | 3.6400 | |
| Non Par | 1.8900 | 3.8100 | |
| Linked | |||
| Par | 0 | 0 | |
| Non Par | 1.1200 | 2.8400 | |
| (b) | With unrealised gains | ||
| Non Linked | |||
| Par | 1.1400 | 3.7100 | |
| Non Par | 1.7800 | 3.7700 | |
| Linked | |||
| Par | 0 | 0 | |
| Non Par | -3.1800 | 5.9800 | |
| (vii) | NPA ratios: (for shareholders' fund) | ||
| (a) | Gross NPAs | 8,325.00 | 8,325.00 |
| Net NPAs | 0.00 | 0.00 | |
| (b) | Percentage of Gross NPAs | 4.2300 | 4.2300 |
| Percentage of Net NPAs | 0 | 0 | |
| (viii) | Yield on Investments (on shareholders' fund) | ||
| (a) | Without unrealised gains | 1.81 | 3.65 |
| (b) | With unrealised gains | 1.96 | 3.80 |
| (ix) | Persistency Ratio | ||
| 1 | 13th Month | 80.7700 | 85.600 |
| 2 | 25th Month | 72.2300 | 73.3500 |
| 3 | 37th Month | 66.0100 | 67.7900 |
| 4 | 49th Month | 60.2900 | 62.0400 |
| 5 | 61st Month | 52.2100 | 54.600 |
| (ix) | Other Rations | ||
| (x) | Conservation Ratio | 82.2600 | 83.4200 |
| (xi) | Percentage of shares held by Government of India (in case of public sector insurance companies) | 0 | 0 |
| Investor Compliants | |||
|---|---|---|---|
| (i) | No of investor complaints pending at the beginning of the period | 0 | 0 |
| (ii) | No of investor complaints during the period | 0 | 0 |
| (iii) | No of investor complaints disposed off during the period | 0 | 0 |
| (iv) | No of investor complaints remaining unresolved at the end of the period | 0 | 0 |
| (c) | Notes Format for financial results by life insurance companies filed with stock exchanges |
|---|---|
| 1. Net Premium Income is Net of Reinsurance 2. Income from Investments (Net) - Policyholders' is Net of Amortization and losses (including capital gains). For the quarter ended 30th September 2026, income is lower compared to the quarter ended 30th June 2026 and the quarter ended 30th September 2025 respectively. This decrease is attributable to the Mark to Market (MTM) impact on investments in equity markets within Unit Linked Funds 3. Transfer of funds from Shareholders' A/c and Transfer of funds to Policyholders' A/c Includes contribution of funds from shareholders accounts towards excess EOM and remuneration of MD/CEOs/WTD/Other KMPs 4. Benefits Paid (Net) is Inclusive of interim and other bonuses and net of reinsurance 5. Expenses other than those related to insurance business is Inclusive of Corporate Social Responsibility expenditure, Interest on Subordinate debt and Penalties (if any) 6. Dividend per share is Interim and Final dividend recommended for respective financial year 7. Advertisement and publicity expenses have been included in other operating expenses for the the current period. 8. Interim Bonus includes Terminal Bonus. 9. Profit carried to Balance Sheet Represents Accumulated Profit 10. Analytical ratios have been calculated as per definition given in IRDAI Analytical ratios disclosure 11. Company has provided 100% provision on CPs and NCDs of IL&FS and IL&FS financial services Ltd, due to default in repayment obligations due to downgrade of rating to Default (D) category. Hence, Net NPA amount would become zero. During the period ended September 30, 2026, the Company received Rs. 285 Lakhs as interim distribution from IL&FS Financial Services Ltd, resulting in a reduction of the NPA provision from Rs. 8,610 Lakhs to Rs. 8,325 Lakhs in the Shareholder Fund. Additionally, the Company received Rs. 120 Lakhs as interim distribution from IL&FS Financial Services Ltd, leading to a reduction of the NPA provision from Rs. 3,237 Lakhs to Rs. 3,117 Lakhs in the Unit Linked Fund. 12. NPA: Profit/Loss on Derivative amount (TRAD & AnnuityR Fund) is being considered as Unrealised Gain/Loss and is included while computing the Yield with Unrealised Gain and realised 13. Persistency ratio (Regular Premium/ Limited Premium Payment under Individual Category): 13.1 Persistency ratios are calculated in accordance with IRDAI (Actuarial, Finance and Investment Functions of Insurers) Regulations, 2024 and the Master circular issued thereafter. Persistency ratios include individual business only, Group business policies have been excluded from the persistency calculation. 13.2 Persistency ratios for the quarter ended September 30, 2026 have been calculated on September 30, 2026 for the policies issued in June to August period of the relevant years. For example, the 13th month persistency for the quarter ended September 30, 2026 is calculated for policies issued from June 1, 2025 to August 31, 2025. 13.3 Persistency ratios for the year ended September 30, 2026 have been calculated on September 30, 2026 for the policies issued in September to August period of the relevant years. For example, the 13th month persistency for year ended September 30, 2026 is calculated for policies issued from September 1, 2024 to August 31, 2025. | |
| Partiuclars | Current Quarter | Year to Date Figures | |
|---|---|---|---|
| Date of start of reporting period | 01-07-2026 | 01-04-2026 | |
| Date of end of reporting period | 30-09-2026 | 30-09-2026 | |
| Whether results are audited or unaudited | Unaudited | Unaudited | |
| Nature of report standalone or consolidated | Standalone | Standalone | |
| Segment Income | |||
| 1 | Name of segment | Linked Non Participating - Life | |
| (i) | Net premium | 92,268.00 | 1,61,146.00 |
| (ii) | Income form investments | (55,693.00) | 1,18,849.00 |
| (iii) | Transfer of funds from shareholders' account | 21.00 | 21.00 |
| (iv) | Other income | 52.00 | 120.00 |
| 2 | Name of segment | Linked Non Participating - Pension | |
| (i) | Net premium | 1,749.00 | 3,778.00 |
| (ii) | Income form investments | (490.00) | 974.00 |
| (iii) | Transfer of funds from shareholders' account | 256.00 | 412.00 |
| (iv) | Other income | 1.00 | 2.00 |
| 3 | Name of segment | Linked Non Participating - Health | |
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 0.00 | 0.00 |
| 4 | Name of segment | Linked Non Participating - Others | |
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 0.00 | 0.00 |
| 5 | Name of segment | Non Linked Participating - Life | |
| (i) | Net premium | 35,288.00 | 54,938.00 |
| (ii) | Income form investments | 15,921.00 | 31,573.00 |
| (iii) | Transfer of funds from shareholders' account | 14.00 | 14.00 |
| (iv) | Other income | 294.00 | 568.00 |
| 6 | Name of segment | Non Linked Participating - Pension | |
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 0.00 | 0.00 |
| 7 | Name of segment | Non Linked Participating - Health | |
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 0.00 | 0.00 |
| 8 | Name of segment | Non Linked Participating - Others | |
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 0.00 | 0.00 |
| 9 | Name of segment | Non Linked Non Participating - Life | |
| (i) | Net premium | 94,442.00 | 1,87,678.00 |
| (ii) | Income form investments | 31,181.00 | 60,941.00 |
| (iii) | Transfer of funds from shareholders' account | (1,520.00) | 47.00 |
| (iv) | Other income | 275.00 | 572.00 |
| 10 | Name of segment | Non Linked Non Participating - Pension | |
| (i) | Net premium | 31,529.00 | 52,457.00 |
| (ii) | Income form investments | 5,729.00 | 11,180.00 |
| (iii) | Transfer of funds from shareholders' account | (301.00) | 383.00 |
| (iv) | Other income | 18.00 | 37.00 |
| 11 | Name of segment | Non Linked Non Participating - Health | |
| (i) | Net premium | 40.00 | 71.00 |
| (ii) | Income form investments | 10.00 | 20.00 |
| (iii) | Transfer of funds from shareholders' account | 16.00 | 17.00 |
| (iv) | Other income | 0.00 | 0.00 |
| 12 | Name of segment | Non Linked Non Participating - Others | |
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 0.00 | 0.00 |
| 13 | Name of segment | Shareholders | |
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 3,514.00 | 6,969.00 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | (125.00) | 8.00 |
| 14 | Name of segment | Unallocated | |
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Transfer of funds from shareholders' account | 0.00 | 0.00 |
| (iv) | Other income | 0.00 | 0.00 |
| Partiuclars | Current Quarter | Year to Date Figures | |
|---|---|---|---|
| Date of start of reporting period | 01-07-2026 | 01-04-2026 | |
| Date of end of reporting period | 30-09-2026 | 30-09-2026 | |
| Whether results are audited or unaudited | Unaudited | Unaudited | |
| Nature of report standalone or consolidated | Standalone | Standalone | |
| Segment Surplus/(Deficit) (net of transfer from shareholders' A/c) | |||
| 1 | Linked Non Participating - Life | (1,789.00) | 945.00 |
| 2 | Linked Non Participating - Pension | (256.00) | (412.00) |
| 3 | Linked Non Participating - Health | 0.00 | 0.00 |
| 4 | Linked Non Participating - Others | 0.00 | 0.00 |
| 5 | Non Linked Participating - Life | 0.00 | 0.00 |
| 6 | Non Linked Participating - Pension | 0.00 | 0.00 |
| 7 | Non Linked Participating - Health | 0.00 | 0.00 |
| 8 | Non Linked Participating - Others | 0.00 | 0.00 |
| 9 | Non Linked Non Participating - Life | 3,747.00 | 2,180.00 |
| 10 | Non Linked Non Participating - Pension | 308.00 | (376.00) |
| 11 | Non Linked Non Participating - Health | (16.00) | (17.00) |
| 12 | Non Linked Non Participating - Others | 0.00 | 0.00 |
| 13 | Shareholders | 2,827.00 | 5,652.00 |
| 14 | Unallocated | 0.00 | 0.00 |
| Partiuclars | Current Quarter | |
|---|---|---|
| Date of start of reporting period | 01-07-2026 | |
| Date of end of reporting period | 30-09-2026 | |
| Whether results are audited or unaudited | Unaudited | |
| Nature of report standalone or consolidated | Standalone | |
| Segment Assets | ||
| 1 | Linked Non Participating - Life | 19,04,805.00 |
| 2 | Linked Non Participating - Pension | 31,945.00 |
| 3 | Linked Non Participating - Health | 0.00 |
| 4 | Linked Non Participating - Others | 0.00 |
| 5 | Non Linked Participating - Life | 9,20,114.00 |
| 6 | Non Linked Participating - Pension | 0.00 |
| 7 | Non Linked Participating - Health | 0.00 |
| 8 | Non Linked Participating - Others | 0.00 |
| 9 | Non Linked Non Participating - Life | 16,87,356.00 |
| 10 | Non Linked Non Participating - Pension | 3,34,318.00 |
| 11 | Non Linked Non Participating - Health | 649.00 |
| 12 | Non Linked Non Participating - Others | 0.00 |
| 13 | Shareholders | 1,88,866.00 |
| 14 | Unallocated | 0.00 |
| Partiuclars | Current Quarter | ||
|---|---|---|---|
| Date of start of reporting period | 01-07-2026 | ||
| Date of end of reporting period | 30-09-2026 | ||
| Whether results are audited or unaudited | Unaudited | ||
| Nature of report standalone or consolidated | Standalone | ||
| Segment Liabilities | |||
| 1 | Linked Non Participating - Life | 19,04,805.00 | |
| 2 | Linked Non Participating - Pension | 31,945.00 | |
| 3 | Linked Non Participating - Health | 0.00 | |
| 4 | Linked Non Participating - Others | 0.00 | |
| 5 | Non Linked Participating - Life | 9,20,114.00 | |
| 6 | Non Linked Participating - Pension | 0.00 | |
| 7 | Non Linked Participating - Health | 0.00 | |
| 8 | Non Linked Participating - Others | 0.00 | |
| 9 | Non Linked Non Participating - Life | 16,87,356.00 | |
| 10 | Non Linked Non Participating - Pension | 3,34,318.00 | |
| 11 | Non Linked Non Participating - Health | 649.00 | |
| 12 | Non Linked Non Participating - Others | 0.00 | |
| 13 | Shareholders | 1,88,866.00 | |
| 14 | Unallocated | 0.00 | |
| Notes to Segment Liabilities | |||
|---|---|---|---|
| Textual Information | 1. Segment Policy Liabilities include funds for future appropriations. | ||
| Particulars | Year ended (dd-mm-yyyy) | |
|---|---|---|
| A | Date of start of reporting period | 01-04-2026 |
| B | Date of end of reporting period | 30-09-2026 |
| C | Whether results are audited or unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Standalone |
| Statement of cash flows | ||
| Cash flows from used in operating activities | ||
| Classes of cash receipts from operating activities | ||
| Receipts from sales of goods and rendering of services | 0.00 | |
| Receipts from royalties fees, commissions and other revenue | 0.00 | |
| Receipts from contracts held for dealing or trading purpose | 0.00 | |
| Receipts from premiums and claims annuities and other policy benefits | 4,85,456.00 | |
| Receipts from rents and subsequent sales of assets held for rental to others and subsequently held for sale | 0.00 | |
| Other cash receipts from operating activities | 630.00 | |
| Classes of cash payments from operating activities | ||
| Payments to suppliers for goods and services | 0.00 | |
| Payments from contracts held for dealing or trading purpose | 0.00 | |
| Payments to and on behalf of employees | 0.00 | |
| Payments for premiums and claims, annuities and other policy benefits | 2,13,926.00 | |
| Payments to manufacture or acquire assets held for rental to others and subsequently held for sale | 0.00 | |
| Other cash payments from operating activities | 1,04,855.00 | |
| Net cash flows from (used in) operations | 1,67,305.00 | |
| Dividends received | 0.00 | |
| Interest paid | 0.00 | |
| Interest received | 0.00 | |
| Income taxes paid (refund) | 699.00 | |
| Other inflows (outflows) of cash | 0.00 | |
| Net cash flows from (used in) operating activities | 1,66,606.00 | |
| Cash flows from used in investing activities | ||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |
| Other cash receipts from sales of equity or debt instruments of other entities | 0.00 | |
| Other cash payments to acquire equity or debt instruments of other entities | 0.00 | |
| Other cash receipts from sales of interests in joint ventures | 0.00 | |
| Other cash payments to acquire interests in joint ventures | 0.00 | |
| Proceeds from sales of property, plant and equipment | 20.00 | |
| Purchase of property, plant and equipment | 744.00 | |
| Proceeds from sales of investment property | 0.00 | |
| Purchase of investment property | 0.00 | |
| Proceeds from sales of goodwill | 0.00 | |
| Purchase of goodwill | 0.00 | |
| Proceeds from sales of intangible assets | 0.00 | |
| Purchase of intangible assets | 0.00 | |
| Proceeds from biological assets other than bearer plants | 0.00 | |
| Purchase of biological assets other than bearer plants | 0.00 | |
| Proceeds from sales of other long-term assets | 0.00 | |
| Purchase of other long-term assets | 0.00 | |
| Cash advances and loans made to other parties | 0.00 | |
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |
| Dividends received | 0.00 | |
| Interest received | 1,18,744.00 | |
| Income taxes paid (refund) | 0.00 | |
| Other inflows (outflows) of cash | (2,92,543.00) | |
| Proceeds from government grants | 0.00 | |
| Net cash flows from (used in) investing activities | (1,74,523.00) | |
| Cash flows from used in financing activities | ||
| Proceeds from changes in ownership interests in subsidiaries that do not result in loss of control | 0.00 | |
| Payments from changes in ownership interests in subsidiaries that do not result in loss of control | 0.00 | |
| Proceeds from issuing shares | 0.00 | |
| Proceeds from issuing other equity instruments | 0.00 | |
| Payments to acquire or redeem entity's shares | 0.00 | |
| Payments of other equity instruments | 0.00 | |
| Proceeds from exercise of stock options | 0.00 | |
| Proceeds from issuing debentures notes bonds etc | 0.00 | |
| Proceeds from borrowings | 0.00 | |
| Repayments of borrowings | 0.00 | |
| Payments of lease liabilities | 0.00 | |
| Dividends paid | 3,800.00 | |
| Interest paid | 0.00 | |
| Income taxes paid (refund) | 0.00 | |
| Other inflows (outflows) of cash | 0.00 | |
| Net cash flows from (used in) financing activities | (3,800.00) | |
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | (11,717.00) | |
| Effect of exchange rate changes on cash and cash equivalents | ||
| Effect of exchange rate changes on cash and cash equivalents /th> | 0.00 | |
| Net increase (decrease) in cash and cash equivalents | (11,717.00) | |
| Cash and cash equivalents cash flow statement at beginning of period | 1,95,113.00 | |
| Cash and cash equivalents cash flow statement at end of period | 1,83,396.00 | |
| Partiuclars | Year ended (dd-mm-yyyy) | ||
|---|---|---|---|
| Date of start of reporting period | 01-04-2026 | ||
| Date of end of reporting period | 30-09-2026 | ||
| Whether results are audited or unaudited | Unaudited | ||
| Nature of report standalone or consolidated | Standalone | ||
| Sources of Funds | |||
| 1 | Share capital | 95,000.00 | |
| 2 | Reserves and surplus | 68,866.00 | |
| 3 | Share application money received pending allotment of shares | 0.00 | |
| 4 | Credit (Debit) Fair value change account | 0.00 | |
| Sub total | 1,63,866.00 | ||
| 5 | Borrowings | 25,000.00 | |
| 6 | Policyholders' funds | ||
| Credit (Debit) Fair value change account | (13,030.00) | ||
| Policy Liabilities | 28,97,135.00 | ||
| Insurance Reserve | 0.00 | ||
| Revaluation reserve - Investment property | 0.00 | ||
| Linked Liabilities | |||
| Provision for Linked Liabilities | 15,61,859.00 | ||
| Change in fairvalue account | 2,25,871.00 | ||
| Funds for Discontinued Policies | |||
| (i) Discontinued on account of non-payment of premium | 1,29,864.00 | ||
| (ii) Credit (Debit) Fair value change account | 0.00 | ||
| (iii) Others discontinuance | 3,014.00 | ||
| Total Linked Liabilities | 19,20,608.00 | ||
| Sub total | 48,04,713.00 | ||
| 7 | Funds for Future Appropriations | 74,474.00 | |
| Total Sources of Funds | 50,68,053.00 | ||
| APPLICATION OF FUNDS | |||
| 1 | Investments shareholders | 1,93,285.00 | |
| 2 | Investments policyholders | 29,06,105.00 | |
| 3 | Assets Held to cover link Liabilities | 19,20,608.00 | |
| 4 | Loans | 28,701.00 | |
| 5 | Fixed assets | 3,447.00 | |
| 6 | Deferred Tax Asset | 0.00 | |
| 7 | Current assets | ||
| Cash and bank balances | 28,196.00 | ||
| Advances and other assets | 1,04,158.00 | ||
| Sub-total (a) | 1,32,354.00 | ||
| 8 | Current liabilities | 1,13,617.00 | |
| 9 | Provisions | 2,830.00 | |
| Sub-total (b) | 1,16,447.00 | ||
| 10 | Net current assets (c) = (a—b) | 15,907.00 | |
| 11 | Miscellaneous expenditure (to the extent not written off or adjusted) | 0.00 | |
| 12 | Debit balance in profit & loss account (shareholders account) | 0.00 | |
| Total | 50,68,053.00 | ||
| 14 | Contigent Liabilities | 34,393.00 | |
| 15 | Notes to the Balance Sheet |
|---|---|
| Notes: 1. The Company does not have any subsidiaries/ associates/ joint venture companies, therefore, consolidated financial statements are not applicable to the Company. 2. The above unaudited financial results have been prepared in accordance with the recognition and measurement principles laid down in Accounting Standard 25 Interim Financial Reporting (AS 25) prescribed under Section 133 of the Companies Act, 2013, the relevant provision prescribed by IRDAI (Actuarial, Finance and Investment Functions of Insurers) Regulations, 2024, requirements of Regulation 33 and Regulation 52 read with Regulation 63(2) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended from time to time, to the extent applicable and IRDAI circular IRDA/F&I/REG/CIR/208/10/2016 dated October 25, 2016 on publication of financial results for life insurance companies. 3. The financial results of the Company for the quarter and six months ended September 30, 2026 were reviewed by the Audit Committee and subsequently approved by the Board of Directors at its meeting held on October 09, 2026. 4. The above financial results have been reviewed by the joint Statutory Auditors of the Company, M. Bhaskara Rao & Co. (Firm Registration No. 000459S) and Brahmayya & Co. (Firm Registration No. 000513S). 5. The amounts for the quarter ended September 30, 2026 are balancing amount between the amount as per financial statements for the six months ended September 30, 2026 and the amount as per financial statements for quarter ended June 30, 2026. The same also applies for the amount for the quarter ended September 30, 2025. 6. In view of seasonality of industry, the results of interim period are not necessarily indicative of the results that may be expected of any other interim periods or for the full year. 7. IRDAI, vide IRDAI (Actuarial, Finance and Investment Functions of Insurers) (Amendment) Regulations, 2026 (“Amended Regulation”) has mandated insurance companies to prepare financial statements in accordance with applicable Indian Accounting Standard (Ind AS) w.e.f. April 1, 2026. The Amended Regulation provides an option to the insurance companies to obtain a forbearance for a period of one year with prior approval of IRDAI. Pursuant to the above, the Company has obtained approval from IRDAI for such forbearance, permitting it to defer the adoption of Ind AS by one year. Accordingly, the Company has prepared its financial statements as per the accounting principles generally accepted in India (Indian GAAP) and Schedule II of the IRDAI (Actuarial, Finance and Investment Functions of Insurers) Regulations, 2024. The joint Auditors have included a emphasis paragraph on this matter in their review report. 8. In accordance with the requirements of IRDAI circular on 'Public Disclosures by Insurers' dated September 30, 2021, the Company will publish the financials on the Company's website latest by October 24, 2026. 9. Figures of the previous period have been re-grouped wherever necessary, to conform to the current year presentation. Cash Flow Notes: 1. Payments for premiums and claims, annuities and other policy benefits includes Payments to the re-insurers, net of commissions and claims, Payments to co-insurers, net of claims recovery and Payments of claims. 2. Other cash payments from operating activities includes Payments of commission and brokerage, Payments of other operating expenses (Includes amount paid towards Corporate Social Responsibility expenditure), Preliminary and pre-operative expenses, Deposits, advances and staff loans and Goods and Service Tax (GST) paid. 3. Other inflows (outflows) of cash in Cash flows from used in investing activities includes Purchase of Investments, Loans against policies, Loan Disbursed (Loan to ESOP Trust), Sale of Investments and Investments in money market instruments and in liquid mutual funds (Net) (includes movement in net current assets). 4. Interest received includes Interests and Dividends received. Related Party Transactions Notes: 1. The Company has entered into Forward Rate Agreement (Fixed Income Derivative instruments) with The Hongkong and Shanghai Banking Corporation Limited towards which the outstanding notional principal as on 30th September 2026 is Rs 6,045 Lakhs (As on 30th September 2025 – Rs. 25,767 Lakhs) and Margin payable on the same as on 30th September 2026 is Rs 443 Lakhs (Margin receivable As on 30th September 2025 – Rs. 776 Lakhs. The Company has also earned an interest income of Rs 16.43 Lakhs on these margins during the period ended 30th September 2026 (As on 30th September 2025 – Rs. 8.34 Lakhs). 2. IPO related expenses recovered from the Shareholders. Since these expense are borne by shareholders therefore omnibus approval was not taken. * The Company may also from time to time receive interest from investments issued by these related parties, in line with the terms of investments so made. | |
Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter) |
| Sr No. | Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken. | ||||||||||||||||||||||||
| Details of the party (listed entity /subsidiary) entering into the transaction | Details of the counterparty | Type of related party transaction | Details of other related party transaction | Value of the related party transaction as approved by the audit committee | Remarks on approval by audit committee | Value of the related party transaction ratified by the audit committee | Date of Audit Committee Meeting where the ratification was approved | Value of transaction during the reporting period | In case monies are due to either party as a result of the transaction | In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments | Details of the loans, inter-corporate deposits, advances or investments | Notes | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | PAN | Name | PAN | Relationship of the counterparty with the listed entity or its subsidiary | Opening balance | Closing balance | Nature of indebtedness (loan/ issuance of debt/ any other etc.) | Details of other indebtedness | Cost | Tenure | Nature (loan/ advance/ intercorporate deposit/ investment ) | Interest Rate (%) | Tenure | Secured/ unsecured | Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage) | ||||||||||
| 1 | Canara HSBC Life Insurance Company Limited | Canara Bank | Promoter | Any other transaction | Premium Income | 2,00,000.00 | - | 60,675.06 | 0.00 | 0.00 | |||||||||||||||
| 2 | Canara HSBC Life Insurance Company Limited | Canara Bank | Promoter | Any other transaction | Benefits Paid | 75,000.00 | - | 1,643.61 | 0.00 | 0.00 | |||||||||||||||
| 3 | Canara HSBC Life Insurance Company Limited | Canara Bank | Promoter | Any other transaction | Commission | 1,00,000.00 | - | 20,928.74 | 1,661.34 | 787.58 | |||||||||||||||
| 4 | Canara HSBC Life Insurance Company Limited | Canara Bank | Promoter | Any other transaction | Rent | 1,000.00 | - | 109.98 | 0.00 | 0.00 | |||||||||||||||
| 5 | Canara HSBC Life Insurance Company Limited | Canara Bank | Promoter | Any other transaction | Reimbursement of expenses- Electricity Charges and Property Tax | 400.00 | - | 54.12 | 0.00 | 0.00 | |||||||||||||||
| 6 | Canara HSBC Life Insurance Company Limited | Canara Bank | Promoter | Any other transaction | Recovery of IPO related expenses (Note 2) | - | 79.43 | 0.00 | 0.00 | ||||||||||||||||
| 7 | Canara HSBC Life Insurance Company Limited | Canara Bank | Promoter | Any other transaction | Bank Charges | 500.00 | - | (20.59) | 0.00 | 0.00 | |||||||||||||||
| 8 | Canara HSBC Life Insurance Company Limited | The Hongkong and Shanghai Banking Corporation Limited | Promoter Group | Any other transaction | Premium Income | 50,000.00 | - | 289.43 | 0.00 | 0.00 | |||||||||||||||
| 9 | Canara HSBC Life Insurance Company Limited | The Hongkong and Shanghai Banking Corporation Limited | Promoter Group | Any other transaction | Commission | 12,500.00 | - | 2,944.61 | 709.77 | 506.83 | |||||||||||||||
| 10 | Canara HSBC Life Insurance Company Limited | The Hongkong and Shanghai Banking Corporation Limited | Promoter Group | Any other transaction | Bank Charges | 200.00 | - | 10.85 | 0.00 | 0.00 | |||||||||||||||
| 11 | Canara HSBC Life Insurance Company Limited | The Hongkong and Shanghai Banking Corporation Limited | Promoter Group | Any other transaction | Margin Receivable/(Payable) (Note 1) | 1,00,000.00 | - | 0.00 | 1,119.00 | (443.00) | |||||||||||||||
| 12 | Canara HSBC Life Insurance Company Limited | The Hongkong and Shanghai Banking Corporation Limited | Promoter Group | Any other transaction | Interest and Investment Income (Note 1) | 1,00,000.00 | - | 16.43 | 0.00 | 0.00 | |||||||||||||||
| 13 | Canara HSBC Life Insurance Company Limited | The Hongkong and Shanghai Banking Corporation Limited | Promoter Group | Any other transaction | Guarantees and Collaterals | 5,000.00 | - | 0.00 | 50.00 | 50.00 | |||||||||||||||
| 14 | Canara HSBC Life Insurance Company Limited | HSBC Insurance (Asia-Pacific) Holdings Limited | Promoter | Any other transaction | Recovery of IPO related expenses (Note 2) | - | 2.74 | 0.00 | 0.00 | ||||||||||||||||
| 15 | Canara HSBC Life Insurance Company Limited | Punjab National Bank | Substantial Interest | Any other transaction | Commission | 2,500.00 | - | 551.99 | 218.60 | 130.06 | |||||||||||||||
| 16 | Canara HSBC Life Insurance Company Limited | Punjab National Bank | Substantial Interest | Any other transaction | Bank Charges | 100.00 | - | 1.31 | 0.00 | 0.00 | |||||||||||||||
| 17 | Canara HSBC Life Insurance Company Limited | Punjab National Bank | Substantial Interest | Any other transaction | Sale / Maturity of Investments* | 25,000.00 | - | 2,538.36 | 0.00 | 0.00 | |||||||||||||||
| 18 | Canara HSBC Life Insurance Company Limited | Punjab National bank | Substantial Interest | Any other transaction | Recovery of IPO related expenses (Note 2) | - | 54.84 | 0.00 | 0.00 | ||||||||||||||||
| 19 | Canara HSBC Life Insurance Company Limited | Canara Bank Securities Limited | Promoter Group | Any other transaction | Brokerage | 300.00 | - | 69.12 | 1.43 | 0.00 | |||||||||||||||
| 20 | Canara HSBC Life Insurance Company Limited | Canara Robeco Asset Management Company Limited | Promoter Group | Any other transaction | Premium Income | 1,000.00 | - | (0.05) | 0.00 | 0.00 | |||||||||||||||
| 21 | Canara HSBC Life Insurance Company Limited | Canara Robeco Asset Management Company Limited | Promoter Group | Any other transaction | Sale / Maturity of Investments* | 10,000.00 | - | 2,451.27 | 0.00 | 0.00 | |||||||||||||||
| 22 | Canara HSBC Life Insurance Company Limited | Karnataka Grameena Bank | Promoter Group | Any other transaction | Premium Income | 20,000.00 | - | 7,922.57 | 0.00 | 0.00 | |||||||||||||||
| 23 | Canara HSBC Life Insurance Company Limited | Karnataka Grameena Bank | Promoter Group | Any other transaction | Commission | 7,500.00 | - | 1,398.83 | 727.12 | 298.69 | |||||||||||||||
| 24 | Canara HSBC Life Insurance Company Limited | Karnataka Grameena Bank | Promoter Group | Any other transaction | Bank Charges | 150.00 | - | 0.14 | 0.00 | 0.00 | |||||||||||||||
| 25 | Canara HSBC Life Insurance Company Limited | Kerala Grameena Bank | Promoter Group | Any other transaction | Premium Income | 5,000.00 | - | 66.88 | 0.00 | 0.00 | |||||||||||||||
| 26 | Canara HSBC Life Insurance Company Limited | Kerala Grameena Bank | Promoter Group | Any other transaction | Commission | 2,500.00 | - | 105.73 | 87.44 | 81.96 | |||||||||||||||
| 27 | Canara HSBC Life Insurance Company Limited | Kerala Grameena Bank | Promoter Group | Any other transaction | Bank Charges | 100.00 | - | 0.02 | 0.00 | 0.00 | |||||||||||||||
| 28 | Canara HSBC Life Insurance Company Limited | Can Fin Homes Limited | Promoter Group | Any other transaction | Premium Income | 15,000.00 | - | 4,467.01 | 0.00 | 0.00 | |||||||||||||||
| 29 | Canara HSBC Life Insurance Company Limited | Can Fin Homes Limited | Promoter Group | Any other transaction | Commission | 2,500.00 | - | 225.48 | 79.47 | 39.53 | |||||||||||||||
| 30 | Canara HSBC Life Insurance Company Limited | Canara HSBC Life Insurance Company Limited Group Gratuity Trust | Gratuity Trust | Any other transaction | Premium Income | 2,500.00 | - | 1,458.98 | 0.00 | 0.00 | |||||||||||||||
| 31 | Canara HSBC Life Insurance Company Limited | Canara HSBC Life Insurance Company Limited Group Gratuity Trust | Gratuity Trust | Any other transaction | Benefits Paid | 2,500.00 | - | 153.88 | 0.00 | 0.00 | |||||||||||||||
| 32 | Canara HSBC Life Insurance Company Limited | Canara HSBC Life Insurance Company Limited Group Gratuity Trust | Gratuity Trust | Any other transaction | Contribution towards Gratuity Plan | 2,500.00 | - | 1,458.98 | 0.00 | 0.00 | |||||||||||||||
| Total value of transaction during the reporting period | 1,09,659.75 | ||||||||||||||||||||||||